论文部分内容阅读
美国伊莱利利公司诉江苏豪森药业股份有限公司侵犯发明专利权纠纷上诉案【最高人民法院(2009)民三终字第6号民事判决书】,被评为2010年中国法院知识产权司法保护十大案件之一,是一起在中国制药领域具有重大影响的、非常复杂的专利侵权案件。本刊特约北京市联德律师事务所刘永全律师和北京市振邦律师事务所戢磊律师从各自不同的角度对本案进行了评析,并探讨了医药专利诉讼相关问题,当中不乏两位律师不同观点的碰撞。
US Eli Lilly Company v Jiangsu Haosen Pharmaceutical Co., Ltd. Infringement of Invention Patent Dispute [Supreme People’s Court (2009) Min San Zhong Zi No. 6 Civil Judgment] was awarded the 2010 Judgment of Intellectual Property of China Court One of the top ten cases of protection is a very complex case of patent infringement that has a significant impact in the pharmaceutical industry in China. Lawyer Liu Yongquan, Beijing Liande Law Firm, Beijing Law Firm and Lawyer Lei Lei from Beijing Zhenbang Law Firm reviewed the case from different perspectives and discussed the issues related to medical patent litigation. Among them, there are many lawyers with different opinions collision.